Mario Pujato - Publications

Affiliations: 
Albert Einstein College of Medicine, New York, New York, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Aivalioti MM, Bartholdy BA, Pradhan K, Bhagat TD, Zintiridou A, Jeong JJ, Thiruthuvanathan VJ, Pujato M, Paranjpe A, Zhang C, Levine RL, Viny AD, Wickrema A, Verma A, Will B. PU.1-dependent enhancer inhibition separates Tet2-deficient hematopoiesis from malignant transformation. Blood Cancer Discovery. PMID 35820129 DOI: 10.1158/2643-3230.BCD-21-0226  0.3
2021 Hass MR, Brissette D, Parameswaran S, Pujato M, Donmez O, Kottyan LC, Weirauch MT, Kopan R. Runx1 shapes the chromatin landscape via a cascade of direct and indirect targets. Plos Genetics. 17: e1009574. PMID 34111109 DOI: 10.1371/journal.pgen.1009574  0.308
2020 Sirvent S, Vallejo AF, Davies J, Clayton K, Wu Z, Woo J, Riddell J, Chaudhri VK, Stumpf P, Nazlamova LA, Wheway G, Rose-Zerilli M, West J, Pujato M, Chen X, et al. Genomic programming of IRF4-expressing human Langerhans cells. Nature Communications. 11: 313. PMID 31949143 DOI: 10.1038/S41467-019-14125-X  0.326
2019 Eapen A, Parameswaran S, Forney C, Miller D, Donmez O, Dunn K, Chawla M, Sauder A, Fjellman E, Pujato M, Lu X, Chen X, Bernstein DI, Weirauch MT, Nesbitt Kottyan LC. NFκB transcription factor binding is altered at many Atopic Dermatitis disease loci Journal of Allergy and Clinical Immunology. 143: AB65. DOI: 10.1016/J.Jaci.2018.12.199  0.35
2018 Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nature Genetics. PMID 29662164 DOI: 10.1038/S41588-018-0102-3  0.345
2018 Barreyro L, Sampson A, Hueneman K, Bolanos LC, Pujato M, Chutipongtanate S, Wyder M, Haffey W, Choi K, Neelamraju Y, Smith MA, Niederkorn M, Ramesh V, Muto T, O'Brien E, et al. Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid Malignancies Blood. 132: 4050-4050. DOI: 10.1182/Blood-2018-99-115359  0.336
2016 Barreyro L, Sampson AM, Bolanos L, Niederkorn M, Pujato M, Smith MA, Tomoya M, Haffey WD, Christie S, Liu X, Weirauch M, Greis K, Seibel WL, Starczynowski DT. Inhibition of UBE2N As a Therapeutic Approach in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Blood. 128: 579-579. DOI: 10.1182/Blood.V128.22.579.579  0.333
2014 Pujato M, Kieken F, Skiles AA, Tapinos N, Fiser A. Prediction of DNA binding motifs from 3D models of transcription factors; identifying TLX3 regulated genes. Nucleic Acids Research. 42: 13500-12. PMID 25428367 DOI: 10.1093/Nar/Gku1228  0.468
2014 Okoye-Okafor UC, Barreyro L, Pujato M, Wang HR, Bartholdy B, Will B, Todorova TI, Kawahara M, Woolcock B, Fiser A, Gascoyne R, Steidl C, Steidl U. Abstract 2945: Characterization of a novel protein-coding gene named TIHL (Translocated in Hodgkin's Lymphoma) Cancer Research. 74: 2945-2945. DOI: 10.1158/1538-7445.Am2014-2945  0.357
2013 Pujato M, MacCarthy T, Fiser A, Bergman A. The underlying molecular and network level mechanisms in the evolution of robustness in gene regulatory networks. Plos Computational Biology. 9: e1002865. PMID 23300434 DOI: 10.1371/Journal.Pcbi.1002865  0.431
2013 Okoye-Okafor UC, Barreyro L, Wang HR, Bartholdy B, Will B, Todorova TI, Narayanagari S, Pujato M, Kawahara M, Woolcock BW, Gascoyne RD, Steidl C, Steidl U. Molecular and Functional Characterization Of The Novel Protein-Coding Gene Tihl (Translocated in Hodgkin’s Lymphoma) in Hematopoiesis Blood. 122: 3680-3680. DOI: 10.1182/Blood.V122.21.3680.3680  0.357
Show low-probability matches.